Injectable Glutathione Products Have Been Recalled
Centric Compounding recalled six lots of products linked to reports of illness in at least four states.
Updated on Sept. 18, 2026 in COVID-19
Live Poll
Do you trust the safety of injectable treatments offered at non-traditional wellness clinics?
Centric Compounding has recalled six lots of injectable glutathione products, including Meyer's Cocktail and Tri-Immune Boost, following reports that at least 30 patients became sick. The products were found to contain elevated levels of endotoxins, which can lead to severe adverse health reactions.
Why it matters
The recall was initiated because these injectable products contained dietary supplement-grade glutathione, which is not FDA-approved for injection and carries a high risk of dangerous contamination. The incident underscores the risks of using compounded injectables that fall outside established safety standards.
As of September 11, 2026, the CDC received reports of over 25 individuals becoming sick across at least four states, with three patients requiring hospitalization. The products were compounded using glutathione labeled as dietary supplement grade from Medisca, Inc.
The players
Centric Compounding
A compounding pharmacy that creates customized medications outside of traditional commercial manufacturing.
FDA
The federal agency responsible for overseeing drug safety and protecting the public from contaminated medical products.
CDC
The national public health agency that conducts disease surveillance and coordinates responses to medical outbreaks.
Medisca, Inc.
A supplier that provided the dietary supplement-grade glutathione used in the compounded products.
The details
Compounding pharmacies prepare medications that are not available through traditional commercial channels. These specific vials contained glutathione sourced as dietary supplement grade, which lacks the regulatory oversight and sterilization requirements of pharmaceutical-grade components. The presence of elevated endotoxins—toxins typically released by bacteria—likely triggered the severe immune responses seen in patients, such as fever, chills, and chest pain.
Timeline
July 2026: The Texas health department notified the CDC of illness reports.
August 2026: The FDA issued an alert regarding the use of supplement-grade glutathione for injectables.
September 11, 2026: The CDC recorded over 25 reports of illness.
September 18, 2026: Centric Compounding issued the recall for six product lots.
Health Landscape
There are currently no FDA-approved injectable glutathione products in the United States. This recall highlights the ongoing regulatory tension regarding the ingredients compounding pharmacies use when creating off-label injectables.
If you have received an injectable glutathione treatment recently and experience symptoms like fever, chills, chest pain, or nausea, contact your physician immediately. Discuss the safety and regulatory status of any compounded medication you are considering with your healthcare provider.
The takeaway
This recall serves as a critical reminder that compounded medications lack the same rigorous safety testing as FDA-approved drugs. Always verify the source and regulatory status of any injectable medication with your doctor before proceeding with treatment.
Further reading
For more information on the standards and safety risks associated with medications, visit our COVID-19 section.
Source note: This article includes information reported by NewsNation.
Live Poll
Do you trust the safety of injectable treatments offered at non-traditional wellness clinics?
